Raia Drogasil S.A. - ADR
RADLY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.48B
Close$
$1.00
61.1% downside
Current Fair Value
61.1% downsideOvervalued by 61.1% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $4.48 Billion |
|---|---|
| Enterprise Value | $12.69 Billion |
| Annual dividend | $0.09 |
| Dividend yield | 3.04% |
| Earnings per Share | $0.77 |
| Beta | 0.01 |
| Outstanding Shares | 1,748,536,237 |
Return
| Return on Equity | 18.64% |
|---|---|
| Return on Assets | 5.41% |
| Return on Invested Capital | 18.77% |
Valuation & Multiples
| P/E Ratio | 20.14 |
|---|---|
| PEG | 125.16 |
| Price to Sales | 0.1 |
| Price to Book Ratio | 0.64 |
| Enterprise Value to Revenue | 0.28 |
| Enterprise Value to EBIT | 4.52 |
| Enterprise Value to Net Income | 9 |
| Total Debt to Enterprise | 0.69 |
| Debt to Equity | 1.2 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 10, 2026
EPS Estimate
$0.05
Consensus analyst estimateRevenue Estimate
$2.29 B
Consensus analyst estimateNext Earnings Call
Expected Date
March 2, 2027
EPS Estimate
$0.05
Consensus analyst estimateRevenue Estimate
$2.16 B
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Raia Drogasil S.A.
75,594 employees
CEO: Renato Raduan
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. The company sells its products through stores, telesales, and call ...